Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Appointed director
|
|
AVENUE THERAPEUTICS, INC. (ATXI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
8-K
| Quarterly results |
| 09/27/2023 |
8-K
| Other Events Interactive Data |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/21/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/12/2023 |
8-K
| Quarterly results|
Docs:
|
"Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights Miami, FL – May 12, 2023 – Avenue Therapeutics, Inc. , a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today reported financial results and recent corporate highlights for the first quarter ended March 31, 2023. “Avenue is progressing its neuro-focused clinical stage pipeline and 2023 is off to a strong start with AJ201, a first in class small molecule for the treatment of Spinal and Bulbar Muscular Atrophy , now in an ongoing Phase 1b/2a clinical trial, and BAER-101, a potentially more tolerable drug for the treatment of epilepsy and acute anxiety, advancing toward Phase 1b studies in each indication. We..." |
|
| 04/17/2023 |
8-K
| Quarterly results |
| 03/08/2023 |
8-K
| Appointed a new director |
| 03/02/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 02/10/2023 |
8-K
| Quarterly results |
| 02/03/2023 |
8-K
| Quarterly results |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/25/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
| 11/10/2022 |
8-K
| Quarterly results |
| 11/08/2022 |
8-K
| Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits Interact... |
| 11/04/2022 |
8-K
| Quarterly results |
| 10/18/2022 |
8-K
| Quarterly results |
| 10/12/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Underwriting Agreement, by and between the Company and Aegis Capital Corp",
"COMMON STOCK PURCHASE WARRANT AVENUE THERAPEUTICS, INC. Warrant Shares: [●] Issuance Date: October 11, 2022 Initial Exercise Date: October 11, 2022 THIS COMMON STOCK PURCHASE WARRANT certifies that Cede & Co. or its registered assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on October 11, 2027 but not thereafter, to subscribe for and purchase from Avenue Therapeutics, Inc., a Delaware corporation , up [●] shares of Common Stock . The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant shall initially be issued and maintained in the form of a security he...",
"PRE-FUNDED COMMON STOCK PURCHASE WARRANT AvENUE THERAPEUTICS, INC. Warrant Shares: [●] Issuance Date: October 11, 2022 Initial Exercise Date: October 11, 2022 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, Cede & Co., or its registered assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from Avenue Therapeutics, Inc., a Delaware corporation , up to [●] shares of Common Stock . The purchase price of one share of Common under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant shall initially be issued and mai...",
"Warrant Agent Agreement" |
|
| 09/30/2022 |
8-K
| Quarterly results |
| 09/22/2022 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 08/31/2022 |
8-K
| Other Events Interactive Data |
| 08/12/2022 |
8-K
| Quarterly results |
| 08/03/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/29/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/25/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 05/13/2022 |
8-K
| Quarterly results |
| 04/05/2022 |
8-K
| Other Events Interactive Data |
| 03/30/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/21/2022 |
8-K
| Other Events Interactive Data |
| 03/08/2022 |
8-K
| Quarterly results |
| 02/16/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/11/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/07/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|